Business & Industry
Strengthening Supply Chain Visibility for Safe Medicines
A comprehensive survey of 5,000 patients across the United States, the United Kingdom, France, and Germany indicates that pharmaceutical manufacturers have a timely opportunity to build consumer trust through enhanced traceability. With six in 10 respondents voicing concern that...
Business & Industry
Novo Nordisk and Orbis Medicines Partner on Oral Therapies for Cardiometabolic Diseases
Danish pharmaceutical company Novo Nordisk and biotechnology developer Orbis Medicines have entered into a drug discovery and licensing agreement valued at up to $1.4 billion to develop oral therapies for cardiometabolic diseases. The program aims to advance oral alternatives...
News
Top 5 AI Molecule Design Software Platforms in 2026
Generating a molecule is easy for a modern AI model. Generating one that a discovery team should actually make is considerably harder. A useful candidate has to satisfy several constraints at once. It may need stronger binding without losing...
Business & Industry
FDA Opens Door to Innovative Approaches for Psychedelic Drug Development Amid Mental Health Crisis
Senior officials at the US Food and Drug Administration have signaled that the agency is open to novel and innovative approaches in the clinical development of psychedelic drugs, citing the worsening mental health crisis across the United States. The...
Business & Industry
ABEC Opens New Biopharmaceutical Manufacturing Facility in Wilson, North Carolina
ABEC is set to open a new manufacturing facility in Wilson, North Carolina, further strengthening its network of biopharmaceutical process equipment and consumables production. A ribbon-cutting ceremony to mark the occasion is scheduled for 24 September, with company leadership,...
Business & Industry
UK Review Recommends ‘L Plates’ for New Healthcare AIs
The National Commission into the Regulation of AI in Healthcare has delivered its long-awaited report, setting out a framework for deploying artificial intelligence tools within the National Health Service in a manner described as "safe, fast, and trusted."
Commissioned by...
Business & Industry
Hengrui Wins World-First Approval for Hetrombopag in Chemotherapy-Induced Thrombocytopenia
Jiangsu Hengrui Pharma has secured a landmark regulatory clearance in China for its oral thrombopoietin (TPO) receptor agonist hetrombopag, making it the first oral TPO agonist anywhere in the world to receive approval for chemotherapy-induced thrombocytopenia (CIT). The approval...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read